Bossa R, Bissoli M, Chiericozzi M, Cozzi R, Galatulas I, Salvatore G
Dipartimento di Farmacologia, Chemioterapia e Tossicologia Medica-E. Trabucchi-, Università di Milano, Italy.
Anticancer Res. 1996 Jan-Feb;16(1):141-3.
Several non catecholamine, non glycoside cardiotonic drugs have been described recently. New compounds include amrinone, sulmazole, milrinone and pimobendan. In an attempt to alleviate or prevent anthracycline toxicity, we have reported that these compounds reduce the negative effects of adriamycin, 4-epiadriamycin and esorubicin in isolated guinea pig atria. The present study reports the effects of a new cardiotonic agent: enoximone. Enoximone was administered after adriamycin (100 micrograms/ml) on the isolated and spontaneously beating atria, and on electrically driven left atria of guinea pig-in normodynamic and hypodynamic conditions. Exposure for 60 minutes to the antitumor drug causes a depression of contractile force (g) and its derivative versus time (dF/dt, as maximal rate of contractile force). The negative effects of adriamycin are antagonised by enoximone (100, 200 micrograms/ml).
最近已经描述了几种非儿茶酚胺、非糖苷类强心药。新的化合物包括氨力农、舒马唑、米力农和匹莫苯丹。为了减轻或预防蒽环类药物的毒性,我们曾报道这些化合物可减轻阿霉素、4-表阿霉素和表柔比星对离体豚鼠心房的负面影响。本研究报告了一种新型强心剂依诺昔酮的作用。在正常动力学和低动力学条件下,将依诺昔酮施用于阿霉素(100微克/毫升)作用后的离体自发搏动心房以及豚鼠的电驱动左心房。暴露于抗肿瘤药物60分钟会导致收缩力(克)及其相对于时间的导数(dF/dt,作为收缩力的最大速率)降低。依诺昔酮(100、200微克/毫升)可拮抗阿霉素的负面影响。